Doxoven
Doxoven (Doxophylline) is a novel bronchodilator. It structurally differs from Theophylline due to the presence of a dioxolane group in position 7. Doxophylline selectively inhibits phosphodiesterase-4 thereby relaxes bronchial smooth muscle. However, differently from Theophylline, Doxophylline appears to have decreased affinities toward adenosine A1 and A2 receptors, which may account for the better safety profile of the drug. Doxophylline is reported to inhibit platelet activating factor (PAF) and generation of leukotriene production.
Features
| Product Name | Doxoven |
| Generic Name | Doxophylline |
| Formulation | Tablet & Syrup |
| Available Pack Size | 100’s, 30’s, 30’s, 1’s & 1’s |
| Available Strength | 200 mg, 400 mg, 400 mg SR Tablet & 100 mg/5 ml (60 ml & 100 ml Syrup) |